CEO Corner
-
CEO Corner: On Leadership
10/4/2018
“I’m often asked what it takes to be a successful biotech CEO, and as one of the relatively few female CEOs in our industry, what it takes to break the proverbial glass ceiling.”
-
My Life As A Recovering VC, Zigging Where Others Zag
9/3/2018
Identifying and acquiring medicines would be relatively facile; however, convincing investors that the medicines were valuable was going to be a real challenge.
-
Key Considerations For Building A Fully Integrated Biopharmaceutical Company
8/2/2018
There are some key points for biotech companies to consider as they begin to transform their business model to one that captures the business continuum more fully.
-
Patients And Biopharma: Trusted Partners In Fighting Rare Diseases
7/5/2018
Partnerships between pharmaceutical companies and patient advocacy groups hold the key to closing the rare-disease treatment gap. Their mutual commitment to improving patient care is the foundation for collaborative innovation in rare-disease education and research.
-
Building A Biotech with A Diversity Mindset
6/1/2018
A diverse workplace is critical to building a successful biotech company. When you’re leading an organization working to bring life-saving drugs to the market, every second matters, and you need to attract and retain the best talent to be successful.
-
Leaders In Biotech: Raising Our Voices Beyond Industry's Walls
5/2/2018
The CEO of Ovid Therapeutics, Jeremy Levin, feels no time has ever been better for biopharma leaders to speak out as part of their commitment to this industry.
-
What Drug Developers Can Learn From Silicon Valley
2/7/2018
Though biotechnology may never be as fast and efficient as software, we can make innovation and development faster — through nothing more than a Silicon-Valley way of thinking.
-
The Emergence Of New Gene Therapy Hubs
1/9/2018
With gene therapy, we are at the dawn of another era of potentially rapid growth in the sector. And companies planning for their futures will once again consider a range of factors in identifying the optimal locations for gene therapy research and production centers.
-
How Moving Up Through The Ranks Can Shape A Biotech CEO
10/10/2017
All CEOs of small, publicly traded biotechs are required to wear many hats in the office every day. That’s why having a leader with a diverse background and experience in a variety of functional areas is an asset. Here we look at some of the various areas of expertise that can help create a more diverse C-suite executive.
-
Successfully Transforming An Organization: An Active Approach
9/8/2017
Rich Daly, Chairman & CEO of Neuralstem, Inc., pens this month column and gives some enlightening anecdotes about what it takes to make "transformational" changes at a biopharma company.